Cell type preference of a novel human derived cell-permeable peptide dNP2 and TAT in murine splenic immune cells S Lim, J Lee, JH Koo, TG Kang, SJ Ha, JM Choi PloS one 11 (5), e0155689, 2016 | 20 | 2016 |
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx TG Kang, KW Kwon, K Kim, I Lee, MJ Kim, SJ Ha, SJ Shin Nature communications 13 (1), 3155, 2022 | 12 | 2022 |
Enriching CCL3 in the tumor microenvironment facilitates T cell responses and improves the efficacy of anti-PD-1 therapy TG Kang, HJ Park, J Moon, JH Lee, SJ Ha Immune Network 21 (3), 2021 | 11 | 2021 |
Protective efficacy and immunogenicity of Rv0351/Rv3628 subunit vaccine formulated in different adjuvants against Mycobacterium tuberculosis infection KW Kwon, TG Kang, A Lee, SM Jin, YT Lim, SJ Shin, SJ Ha Immune Network 23 (2), 2023 | 3 | 2023 |
Immortalized nanodendritic cells decorated with immune-checkpoint inhibitors for personalized cancer immunotherapy D Choi, TG Kang, T Kim, CW Moon, M Choi, DH Kim, T Kim, Y Oh, S Jung, ... Nano Today 56, 102237, 2024 | | 2024 |